ASP1517

DRUG5 trials

Sponsors

Astellas Pharma Inc

Conditions

Anemia in Chronic Kidney Disease Patients Not on DialysisHealthy SubjectsHealthy Volunteers

Phase 1

Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers

CompletedNCT00978198

Astellas Pharma IncHealthy Volunteers

Start: 2009-09-30End: 2010-06-30Updated: 2010-06-22

Pharmacokinetic Study of ASP1517 With Kremezin®

CompletedNCT02693613

Astellas Pharma IncHealthy Volunteers

Start: 2016-02-29End: 2016-04-30Updated: 2016-06-21

A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517

CompletedNCT02805374

Astellas Pharma IncHealthy Subjects

Start: 2016-07-31End: 2016-08-31Updated: 2016-08-24

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

CompletedNCT02952040

Astellas Pharma IncHealthy Subjects

Start: 2016-11-30End: 2016-12-31Updated: 2017-01-25

Phase 2

ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-

CompletedNCT01964196

Astellas Pharma IncAnemia in Chronic Kidney Disease Patients Not on Dialysis

Start: 2013-09-17End: 2015-12-01Updated: 2024-10-30

Related Papers

Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.

2019-04-0571 citations